Table 4 Summary of clinical outcomes stratified by group.
Outcome | Total (n = 145) | AML ICU Cases (n = 45) | AML non-ICU Controls (n = 50) | Non-AML ICU Controls (n = 225) | p-value |
|---|---|---|---|---|---|
ICU death (%) | 83 (30.7) | 17 (37.8) | - | 66 (29.3) | 0.29 |
Hospital death (%) | 121 (37.8) | 20 (44.4) | 9 (18.0) | 92 (40.9) | 0.004 |
28-Day death (%) | 98 (30.6) | 17 (37.8) | 8 (16.0) | 73 (32.4) | 0.03 |
90-Day death (%) | 132 (41.3) | 23 (51.1) | 16 (32.0) | 93 (41.3) | 0.17 |
1-Year death (%) | 178 (55.6) | 32 (71.1) | 27 (54.0) | 119 (52.9) | 0.08 |
ICU length of stay (days) | 4 (2-11) | 5 (2-12) | - | 4 (2-11) | 0.38 |
   Survived | 5 (2-12) | 8 (2-14) | - | 5 (3-11) | 0.44 |
   Dead | 2 (1-5) | 4 (1-7) | - | 1 (1-3) | 0.17 |
Hospital length of stay (days) | 15 (6-39) | 22 (11-47) | 24 (9-35) | 13 (5-36) | 0.12 |
   Survived | 21 (10-45) | 37 (18-50) | 25 (12-35) | 17 (10-44) | 0.22 |
   Dead | 14 (9-28) | 13 (9-19) | 6 (1-28) | 3 (1-12) | 0.17 |
Median survival (95% CI) (days) | 207 (14-2442) | 82 (14-700) | 274 (55-1303) | 258 (9-2442) | 0.01 |